Skip to main content
Premium Trial:

Request an Annual Quote

Affy Officials: ParAllele Acquisition Closed Friday

NEW YORK, Oct. 24 (GenomeWeb News) - Affymetrix was scheduled to close its acquisition of ParAllele by the end of the day on Friday, according to company officials who spoke during a conference call to discuss the company's third-quarter earnings after market close on Thursday.

 

On Friday, an Affymetrix spokesman confirmed the company's plan to wrap up the acquisition by the end of the day, telling GenomeWeb News that Affymetrix expected to formally announce it today.   

 

Affymetrix announced its plans to purchase ParAllele for $120 million in stock in June. The acquisition was originally scheduled to close by Sept. 30.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.